BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29601129)

  • 1. Effect of histone deacetylase inhibitor on epithelial-mesenchymal transition of liver fibrosis.
    Ramzy MM; Abdelghany HM; Zenhom NM; El-Tahawy NF
    IUBMB Life; 2018 Jun; 70(6):511-518. PubMed ID: 29601129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
    Wang Y; Zhao L; Jiao FZ; Zhang WB; Chen Q; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):423-429. PubMed ID: 30249543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.
    Shen X; Cheng S; Peng Y; Song H; Li H
    BMC Complement Altern Med; 2014 Oct; 14():418. PubMed ID: 25345787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs.
    Peng J; Li X; Feng Q; Chen L; Xu L; Hu Y
    Exp Biol Med (Maywood); 2013 Jun; 238(6):668-77. PubMed ID: 23918878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
    Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
    Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate blocks the transforming growth factor (TGF)-β1 autocrine loop and attenuates the TGF-β1-induced collagen synthesis in a human hepatic stellate cell line.
    Watanabe T; Tajima H; Hironori H; Nakagawara H; Ohnishi I; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Tani T; Fujimura T; Ota T; Wakayama T; Iseki S; Harada S
    Int J Mol Med; 2011 Dec; 28(6):919-25. PubMed ID: 21822535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
    Shrestha N; Chand L; Han MK; Lee SO; Kim CY; Jeong YJ
    Food Chem Toxicol; 2016 Jul; 93():129-37. PubMed ID: 27137983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.
    Aher JS; Khan S; Jain S; Tikoo K; Jena G
    Hum Exp Toxicol; 2015 Jan; 34(1):44-55. PubMed ID: 24812151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Anluohuaxianwan on transforming growth factor-β1 and related signaling pathways in rats with carbon tetrachloride-induced liver fibrosis].
    Lu W; Gao YH; Wang ZZ; Cai YS; Yang YQ; Miao YQ; Pei F; Liu XE; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):257-262. PubMed ID: 28494543
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways.
    Park JH; Park B; Park KK
    Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28406452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
    He J; Bai K; Hong B; Zhang F; Zheng S
    Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stephania tetrandra prevents and regresses liver fibrosis induced by carbon tetrachloride in rats.
    Chor JS; Yu J; Chan KK; Go YY; Sung JJ
    J Gastroenterol Hepatol; 2009 May; 24(5):853-9. PubMed ID: 19220659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
    Tao YY; Wang QL; Shen L; Fu WW; Liu CH
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.
    Mao Y; Zhang S; Yu F; Li H; Guo C; Fan X
    Int J Mol Sci; 2015 Sep; 16(9):21911-30. PubMed ID: 26378522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
    Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
    J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
    Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
    Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.